Gastric adenocarcinoma Trials in Fuzhou, China
Conditions / Gastric adenocarcinoma / Fuzhou, China
Gastric adenocarcinoma has been the subject of sustained clinical investigation across multiple research sites.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03788174 | Apatinib Combined With POF for Second-line Treatment of Gastric Adenocarcinoma | UNKNOWN | PHASE2 |
| NCT04121039 | Study of the Apatinib Combine With POF Versus POF in Gastric Cancer | UNKNOWN | PHASE2 |
| NCT04152499 | Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT03707639 | Study of the Combination of Apatinib and POF | UNKNOWN | PHASE2 |
| NCT04581473 | Study to Evaluate the Efficacy, Safety and Pharmacokinetics of CT041 Autologous CAR T-cell Injection | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2 |
| NCT07029269 | Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer | RECRUITING | PHASE3 |
| NCT05008783 | A Study of AK104 in the First-line Treatment of Locally Advanced Unresectable or Metastatic G/GEJ Adenocarcinoma | COMPLETED | PHASE3 |
| NCT02915432 | The Study to Evaluate Toripalimab (JS001) in Patients With Advanced GC, ESCC, NPC, HNSCC | UNKNOWN | PHASE1/PHASE2 |
| NCT06938139 | Defining Benchmarks for Gastric Cancer Patients Underwent Minimal Invasive Gastrectomy | ACTIVE_NOT_RECRUITING | — |
| NCT02898077 | A Study of Paclitaxel With or Without Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Cancer | COMPLETED | PHASE3 |